1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
PharmSource: Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2023
Summary
This report is the 6th edition of our long-running analysis of the injectables CMO industry. It provides an expert quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products. It combines the rich data resources of PharmSource and the author's Pharmaceutical Intelligence Center with 20 years’ experience in analyzing the injectables CMO industry to provide the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
Scope
Reasons to buy
This 70-page report gives important, expert insight you won’t find in any other source. Over 25 tables and graphs throughout the report illustrate major points and trends.
This report is required reading for:
Summary
This report is the 6th edition of our long-running analysis of the injectables CMO industry. It provides an expert quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products. It combines the rich data resources of PharmSource and the author's Pharmaceutical Intelligence Center with 20 years’ experience in analyzing the injectables CMO industry to provide the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
Scope
- The report is based on the most recent data on industry capacity, the injectables pipeline and the behaviors of the key biopharmaceutical industry actors.
- The model and assumptions are fully explained so you can understand how the analysis was driven and how conclusions were reached.
Reasons to buy
This 70-page report gives important, expert insight you won’t find in any other source. Over 25 tables and graphs throughout the report illustrate major points and trends.
This report is required reading for:
- CMO executives who must have deep understanding of the injectables marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Note: Product cover images may vary from those shown
Chapter 1: Executive Summary
Chapter 2: Objectives and Methodology
Chapter 3: Recent Trends in Injectables NDA/BLA Approvals
Chapter 4: Injectables Pipeline
Chapter 5: Demand Forecast for CMO Capacity
Chapter 6: CMO Industry Capacity analysis
Chapter 7: Supply-Demand Balance and Implications
List of Tables
List of Figures
Note: Product cover images may vary from those shown